Mo­roc­can gov­ern­ment drops $500M in­to new Re­ci­pharm fill-fin­ish plant in big boost for African man­u­fac­tur­ing

Re­ci­pharm has inked a deal with the Mo­roc­can gov­ern­ment to build a new fill-fin­ish fac­to­ry over the next five years to up vac­cine and ther­a­peu­tic ca­pac­i­ty and ca­pa­bil­i­ty, the com­pa­ny an­nounced Tues­day.

The Mo­roc­can gov­ern­ment will in­vest $500 mil­lion in the build, which will be pri­ma­ry ded­i­cat­ed to African vac­cine man­u­fac­ture.

The fac­to­ry will be op­er­a­tional by 2023, if all goes ac­cord­ing to plan, and will mir­ror the com­pa­ny’s cur­rent fill-fin­ish site in Monts, France; ex­cept at 107,000 square feet, it will be op­er­at­ing on a much larg­er scale. Re­ci­pharm will not be on the hook for any of the mon­ey go­ing in­to the plant, just its op­er­a­tions, a spokesper­son for the com­pa­ny con­firmed in an email to End­points News on Thurs­day.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER